Zongwei Lin

519 total citations
19 papers, 388 citations indexed

About

Zongwei Lin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Zongwei Lin has authored 19 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Zongwei Lin's work include Cardiovascular Function and Risk Factors (4 papers), Heart Failure Treatment and Management (3 papers) and T-cell and B-cell Immunology (3 papers). Zongwei Lin is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), Heart Failure Treatment and Management (3 papers) and T-cell and B-cell Immunology (3 papers). Zongwei Lin collaborates with scholars based in China, Bangladesh and Taiwan. Zongwei Lin's co-authors include Qunye Zhang, Huixia Lu, Xiaowei Wang, Xiaoping Ji, Zhe Wang, Jianwei Ren, Shucui Zhang, Xiaoming Zhou, Yue Liu and Xinhuan Su and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Zongwei Lin

17 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zongwei Lin China 10 204 90 74 69 46 19 388
Daniel Mar United States 11 280 1.4× 58 0.6× 80 1.1× 51 0.7× 31 0.7× 17 493
Chihiro Horimai Japan 7 155 0.8× 47 0.5× 45 0.6× 61 0.9× 56 1.2× 9 378
Fang Pei China 12 236 1.2× 158 1.8× 92 1.2× 58 0.8× 26 0.6× 16 409
Yajing Lu China 12 178 0.9× 134 1.5× 76 1.0× 46 0.7× 24 0.5× 21 406
Xiao Lei Moore Australia 9 119 0.6× 35 0.4× 42 0.6× 69 1.0× 34 0.7× 9 446
Anna Kieronska‐Rudek Poland 9 93 0.5× 51 0.6× 35 0.5× 53 0.8× 50 1.1× 17 282
Yukiyo Ogata Japan 9 140 0.7× 39 0.4× 55 0.7× 94 1.4× 46 1.0× 17 345
Jinru Wei China 9 123 0.6× 45 0.5× 76 1.0× 37 0.5× 29 0.6× 15 287
Ning Huangfu China 9 247 1.2× 142 1.6× 88 1.2× 58 0.8× 18 0.4× 26 451
Zhihui Wang China 13 273 1.3× 149 1.7× 30 0.4× 26 0.4× 47 1.0× 35 494

Countries citing papers authored by Zongwei Lin

Since Specialization
Citations

This map shows the geographic impact of Zongwei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongwei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongwei Lin more than expected).

Fields of papers citing papers by Zongwei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongwei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongwei Lin. The network helps show where Zongwei Lin may publish in the future.

Co-authorship network of co-authors of Zongwei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zongwei Lin. A scholar is included among the top collaborators of Zongwei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongwei Lin. Zongwei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Fen, Xiaoxing Li, Jie Xiao, et al.. (2024). STING deficiency alleviates ferroptosis through FPN1 stabilization in diabetic kidney disease. Biochemical Pharmacology. 222. 116102–116102. 18 indexed citations
2.
Wang, Chen, Zongwei Lin, Hui Zhang, et al.. (2023). Dose Titration of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction: A Real-World Study. ESC Heart Failure. 10(3). 1961–1971. 11 indexed citations
3.
Lin, Zongwei, Hui Zhang, Rui Tang, et al.. (2023). Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension. Journal of Geriatric Cardiology. 20(12). 855–866. 2 indexed citations
4.
Zhang, Xinyu, Yijun Sun, Ying Li, et al.. (2023). Association between visceral adiposity index and heart failure: A cross‐sectional study. Clinical Cardiology. 46(3). 310–319. 31 indexed citations
5.
Huang, Shu‐Wei, Zongwei Lin, Tsung‐Hsing Chen, et al.. (2023). Present role of intraoperative enteroscopy in small bowel bleeding: A tertiary center experience. Advances in digestive medicine. 11(2). 74–80. 1 indexed citations
6.
Lin, Zongwei, et al.. (2023). Association Between Epicardial Adipose Tissue and Left Atrial and Ventricular Function in Patients With Heart Failure: A Systematic Review and Meta-Analysis. Current Problems in Cardiology. 48(12). 101979–101979. 14 indexed citations
7.
Lin, Zongwei, Ying Li, Xiangyun Chen, et al.. (2023). Comparisons of Two-dimensional Echocardiographic Aortic Dimensions Between Chinese, Japanese, and Europeans. Journal of Thoracic Imaging. 38(6). 399–406.
8.
Fu, Kang, et al.. (2022). Risk Factors for Intracardiac Thrombus in Peripartum Cardiomyopathy: A Retrospective Study in China. ESC Heart Failure. 10(1). 148–158. 4 indexed citations
9.
Zhang, Xinyu, et al.. (2022). Red Cell Distribution Width is Associated with Short-Term Mortality in Critically Ill Patients with Heart Failure. ESC Heart Failure. 9(5). 3210–3220. 8 indexed citations
10.
Fu, Kang, Yue Hu, Hui Zhang, et al.. (2021). Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment. Frontiers in Cardiovascular Medicine. 8. 760152–760152. 12 indexed citations
11.
Zhang, Shucui, Shigang Zhang, Zongwei Lin, et al.. (2020). Deep sequencing reveals the skewed B-cell receptor repertoire in plaques and the association between pathogens and atherosclerosis. Cellular Immunology. 360. 104256–104256. 7 indexed citations
12.
Su, Xinhuan, Xianlun Yin, Yue Liu, et al.. (2020). Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves’ Disease Patients by Propionic Acid. The Journal of Clinical Endocrinology & Metabolism. 105(11). 3526–3547. 101 indexed citations
13.
Zhou, Peng, Mengqi Guo, Lei Wang, et al.. (2019). Ginsenoside Rb1 ameliorates CKD‐associated vascular calcification by inhibiting the Wnt/β‐catenin pathway. Journal of Cellular and Molecular Medicine. 23(10). 7088–7098. 51 indexed citations
14.
Lin, Zongwei, Chen‐Ming Hsu, Hao‐Tsai Cheng, et al.. (2019). The diagnostic yield and risk of screening colonoscopy in geriatric subjects older than 80 years. Advances in digestive medicine. 7(2). 63–67.
15.
Lin, Zongwei, et al.. (2019). <p>Notch pathway is involved in the suppression of colorectal cancer by embryonic stem cell microenvironment</p>. OncoTargets and Therapy. Volume 12. 2869–2878. 8 indexed citations
16.
Lin, Zongwei, Junfeng Ge, Zhe Wang, et al.. (2017). Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk. Scientific Reports. 7(1). 42498–42498. 74 indexed citations
17.
Lin, Zongwei, Yan Gong, Jianwei Ren, et al.. (2017). Deep sequencing of the T cell receptor β repertoire reveals signature patterns and clonal drift in atherosclerotic plaques and patients. Oncotarget. 8(59). 99312–99322. 17 indexed citations
18.
Lu, Ting, Zongwei Lin, Jianwei Ren, et al.. (2016). The Non-Specific Binding of Fluorescent-Labeled MiRNAs on Cell Surface by Hydrophobic Interaction. PLoS ONE. 11(3). e0149751–e0149751. 9 indexed citations
19.
Wang, Zhe, Rongrong Zhang, Zongwei Lin, et al.. (2014). Integrative Analysis of mRNA and miRNA Array Data Reveals the Suppression of Retinoic Acid Pathway in Regulatory T Cells of Graves' Disease. The Journal of Clinical Endocrinology & Metabolism. 99(12). E2620–E2627. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Mar Breakdown of academic impact, for papers by Chihiro Horimai Breakdown of academic impact, for papers by Fang Pei Breakdown of academic impact, for papers by Yajing Lu Breakdown of academic impact, for papers by Xiao Lei Moore Breakdown of academic impact, for papers by Anna Kieronska‐Rudek Breakdown of academic impact, for papers by Yukiyo Ogata Breakdown of academic impact, for papers by Jinru Wei Breakdown of academic impact, for papers by Ning Huangfu Breakdown of academic impact, for papers by Zhihui Wang
Rankless by CCL
2026